Veradigm Company Insiders
| MDRX Stock | USD 4.60 0.33 6.69% |
Veradigm employs about 2.5 K people. The company is managed by 23 executives with a total tenure of roughly 21 years, averaging almost 0.0 years of service per executive, having 106.52 employees per reported executive. Break down of Veradigm's management performance can provide insight into the company performance.
Veradigm Management Team Effectiveness
Veradigm's management efficiency ratios could be used to measure how well Veradigm manages its routine affairs as well as how well it operates its assets and liabilities.Veradigm shows a total of 108.9 Million outstanding shares. 30% of Veradigm outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Veradigm in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Veradigm, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Veradigm Workforce Comparison
Veradigm is regarded third in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 37,379. Veradigm holds roughly 2,450 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Veradigm Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Veradigm insiders, such as employees or executives, is commonly permitted as long as it does not rely on Veradigm's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Veradigm insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Stonehill Capital Management Llc over two weeks ago Acquisition by Stonehill Capital Management Llc of 2679000 shares of Veradigm at 6.81 subject to Rule 16b-3 | ||
Leah Jones over two weeks ago Disposition of 6866 shares by Leah Jones of Veradigm at 12.53 subject to Rule 16b-3 | ||
Ho Shih Yin over a month ago Disposition of tradable shares by Ho Shih Yin of Veradigm subject to Rule 16b-3 | ||
Zierhoffer Carol J over a year ago Acquisition by Zierhoffer Carol J of 17462 shares of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 |
Veradigm Notable Stakeholders
A Veradigm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Veradigm often face trade-offs trying to please all of them. Veradigm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Veradigm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Langan | President Officer | Profile | |
| Alan Fowles | President International | Profile | |
| Richard Poulton | Pres and CFO | Profile | |
| Gregory Garrison | Independent Director | Profile | |
| MD MBA | Interim Director | Profile | |
| Donald Trigg | Chief Director | Profile | |
| Dave Dornstreich | VP Division | Profile | |
| Elliot Bryant | Senior Unit | Profile | |
| Tehsin Syed | Chief Officer | Profile | |
| Lisa CPC | Senior Officer | Profile | |
| John Mayr | Senior Organization | Profile | |
| Rebecca Whaley | VP Marketing | Profile | |
| John Sage | Senior Sales | Profile | |
| Joseph Rostock | Sr CTO | Profile | |
| Richard Elmore | Senior Strategy | Profile | |
| Tejal JD | General Affairs | Profile | |
| Paul Lewis | Sr Mang | Profile | |
| Leland Westerfield | Interim Officer | Profile | |
| Tejal Vakharia | General Affairs | Profile | |
| Stella Chang | Executive Division | Profile | |
| Tally Baker | Chief Officer | Profile | |
| Jenny Gelinas | Vice Relations | Profile | |
| Leah Jones | Chief Officer | Profile |
About Veradigm Management Performance
The success or failure of an entity such as Veradigm often depends on how effective the management is. Veradigm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Veradigm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Veradigm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people.
Please note, the imprecision that can be found in Veradigm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Veradigm. Check Veradigm's Beneish M Score to see the likelihood of Veradigm's management manipulating its earnings.
Veradigm Workforce Analysis
Traditionally, organizations such as Veradigm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Veradigm within its industry.Veradigm Manpower Efficiency
Return on Veradigm Manpower
| Revenue Per Employee | 240K | |
| Revenue Per Executive | 25.6M | |
| Net Income Per Employee | 54.9K | |
| Net Income Per Executive | 5.8M | |
| Working Capital Per Employee | 87.5K | |
| Working Capital Per Executive | 9.3M |
Additional Tools for Veradigm Stock Analysis
When running Veradigm's price analysis, check to measure Veradigm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veradigm is operating at the current time. Most of Veradigm's value examination focuses on studying past and present price action to predict the probability of Veradigm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veradigm's price. Additionally, you may evaluate how the addition of Veradigm to your portfolios can decrease your overall portfolio volatility.